Nick Brazell

Nick Brazell is a seasoned finance professional specializing in SEC reporting and technical accounting, currently serving as Senior Manager at Kestra Medical Technologies, Inc. since September 2025. Prior to this role, Nick held multiple positions at Nautilus Biotechnology, progressing from Manager to Senior Manager in External Reporting and Technical Accounting from August 2022 to August 2025. Earlier experience includes a Financial Reporting Manager role at Silverback Therapeutics from March 2021 to August 2022, and a series of positions at EY, including Audit Manager and Audit Senior, from September 2015 to February 2021. Nick began his career at EY as an Audit Intern and also gained tax experience as a State & Local Tax Intern at Weyerhaeuser. Nick holds a Bachelor of Arts in Accounting from Seattle University, earned in 2014.